Tokyo, April 3 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061142) titled 'Investigation of Odor as a Trigger in Patients with Migraine' on April 3.
Study Type:
Interventional
Study Design:
Basic Design - Parallel
Randomization - Randomized
Blinding - Single blind -participants are blinded
Control - Placebo
Primary Sponsor:
Institute - Keio University School of Medicine
Condition:
Condition - migraine
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To clarify the relationship between odors and headaches in patients with migraine.
Basic objectives2 - Others
Intervention:
Interventions/Control_1 - Study participants will inhale an odorant.
Interventions/Control_2 - Study participants will inhale a mild odorant.
Eligibility:
Age-lower limit - 18
years-old
<=
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - Patients with migraine who visit Keio University Hospital or Japanese Red Cross Shizuoka Hospital and have agreed to inhale an odor and respond to questionnaires.
Key exclusion criteria - Patients who are pregnant or suspected of being pregnant.
Patients with severe diseases who are considered unable to participate in the study.
Patients who are judged to be unsuitable for participation in this study, etc.
Target Size - 60
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2026 Year 04 Month 02 Day
Anticipated trial start date - 2026 Year 04 Month 03 Day
Last follow-up date - 2029 Year 03 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000069956
Disclaimer: Curated by HT Syndication.
